Small molecules targeting glycogen synthase kinase 3 as potential drug candidates for the treatment of retinitis pigmentosa

• Główni autorzy: Miguel Marchena (Autor), Beatriz Villarejo-Zori (Autor), Josefa Zaldivar-Diez (Autor), Valle Palomo (Autor), Carmen Gil (Autor), Catalina Hernández-Sánchez (Autor), Ana Martínez (Autor), Enrique J. de la Rosa (Autor)
• Format: Książka
• Wydane: Taylor & Francis Group, 2017-01-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Retinitis pigmentosa (RP) is an inherited retinal dystrophy that courses with progressive degeneration of retinal tissue and loss of vision. Currently, RP is an unpreventable, incurable condition. We propose glycogen synthase kinase 3 (GSK-3) inhibitors as potential leads for retinal cell neuroprote...